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ABSTRACT
Introduction: Oral squamous cell carcinoma (OSCC) is one of the highest-ranking cancers among both genders in Pakistan. Obesity
is linked to a much higher risk for developing multiple cancer types. Individuals with Diabetes mellitus (DM) face an increased risk for developing oral cancer. Hence, the objective of this study was to identify the effect of obesity and DM on the prognosis of OSCC patients.
Methods: This retrospective cohort analysis was conducted on 386 patients diagnosed and treated for OSCC at The Aga Khan University
Hospital, Karachi, Pakistan. Patient information was obtained from hospital medical records. Obesity was defined as having a body mass
index (BMI) of ⩾25 kg/m2 according to the WHO Asian cut-offs for BMI. Patient BMI was correlated with diabetes status, clinicopathological
features and overall survival. Kaplan-Meier survival analysis was performed, along with univariate and multivariate cox regression analysis
to test the effect of obesity and diabetes on overall survival.
Results: In a set of 386 patients, there were 296 males (76.7%) and 90 females (23.3%). The mean BMI was 24.4 (SD ± 5.25) and 42.7%
of patients were found to be obese (⩾25 BMI). 64 patients (16.6%) were diabetic. The risk of death was significantly higher in underweight
patients (P = .035) compared with normal weight individuals. Diabetics had a higher mean BMI compared with non-diabetics. However, DM
was not a statistically valid predictor of survival.
Conclusion: Underweight OSCC patients were at a higher risk of death compared with normal weight OSCC patients.
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Introduction

Obesity is widely known as a leading cause of patient morbidity and mortality. As an invaluable indicator of patient
nutrition status, body mass index (BMI) is frequently assessed
in oncological investigations. Previous reports highlight the
effect of BMI on treatment outcomes of breast, colorectal,
oesophageal, and other cancers.5 Moreover, some have suggested that about 3.6% of all cancer cases may be attributable
to a high BMI,6 while others have indicated that weight gain
and obesity may cause up to 20% of all cancer cases.7
There is limited data on the prevalence of obesity among
the Pakistani population, however, available statistics show that
a quarter of the population of Pakistan is overweight or obese.
Middle-aged females of Pakistan have been reported to have
the highest rates of obesity of any other group. A developing
country such as Pakistan appears to be at a greater risk for

Oral squamous cell carcinoma (OSCC) ranks as the sixth most
common head and neck malignancy and makes up about 90% of
all oral cavity cases. In Pakistan, it is the leading cancer in males
and the second-highest in females.1 The most common presentation for oral cancer in Pakistan is a male in his forties, with a
low socioeconomic background and mouth habits that increase
the risk for developing oral cancer.2 In Karachi alone, the consumption of certain forms of chewing tobacco (gutka/niswar),
cigarette smoking, alcohol, betel quid (paan), areca nut (chaliya),
and their combinations have become a leading cause for oral
malignancies.3 Moreover, viral infections such as Human
Papillomavirus (HPV) infection also increase the risk of developing oral cancer. HPV is a causative factor in up to 20% of oral
cancers and 60% to 80% of oropharyngeal cancers.4

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial
4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without
further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
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obesity-associated diseases, and a large part of the population is
at risk of disability or even death.8 A study by Khan et al9 also
observed increasing comorbidities with increasing level of fatness in a dose-dependent fashion in the Pakistani population.
The term diabetes mellitus (DM) broadly refers to a group
of metabolic disorders resulting from defects in insulin secretion and action, eventually leading to hyperglycaemia.10,11 In
Pakistan, the prevalence of DM among individuals >5 years of
age was noted to be 12%.12 In 2000, it was reported that 5.2
million individuals suffered from diabetes and this number is
predicted to increase to 13.9 million by the year 2030.12
Although there have been several investigations regarding the
role of diabetes in OSCC, the results so far are inconclusive.13
It has been seen that diabetic OSCC patients suffer from a
severe increase in risk of disease recurrence and mortality.14 A
meta-analysis of 13 studies conducted in 2015, including Asian
studies, revealed diabetics to be at a higher risk of developing
oral precancerous lesions and cancer, in comparison to nondiabetics. Furthermore, Type 2 DM is also associated with
increased oral cancer mortality13 and survival among diabetics
was lower than non-diabetics.15
There is a need to evaluate the impact of obesity, and its
association with DM, in oral cancer patients among the
Pakistani population which can potentially lead to the betterment of cancer care.15 This study was aimed towards determining the demographic and clinicopathological factors associated
with obesity among oral cancer patients and the association of
DM and obesity with overall survival among OSCC patients.

Materials and Methods
Study design and patient population
For this study, we conducted a retrospective cohort analysis at
The Aga Khan University Hospital (AKUH) Karachi, Pakistan.
386 patients who were diagnosed with biopsy proven squamous cell carcinoma of oral cavity and underwent surgery at
AKUH from January 2008 to December 2013 were recruited.

Data sources
Data were collected on patient demographics, tumour site,
tumour size, histological classification, lymph node involvement, preoperative body mass index (BMI) and DM status
(both type 1 and type 2) from the hospital medical records.
Patients follow up at their last clinic visit was also obtained
from hospital medical records and patients were reported as
either alive or dead. Patients with incomplete medical records
and those who sought treatment outside AKU after their initial
visit were excluded from the study.

Ethical considerations
Since this was study was conducted retrospectively using the
hospital’s records, no patients were contacted directly. This

study was granted exemption from ethical review committee of
AKUH (ERC# 4335-Sur-ERC-16).

Assessment of body mass index (BMI)
Body mass index or Quetelet index is a measure of the relative
size of the body and is defined as body mass in kilograms (kg)
divided by the square of height in metres (m2).16 The World
Health Organization (WHO) defines a BMI as underweight
(<18.5 kg/m2), normal (18.5-–24.9 kg/m2), overweight (25.029.9 kg/m2) and obese (⩾30 kg/m2) internationally. Specific to
Asians, the cut-off values of overweight and obesity are lower
than the WHO criteria to consider the higher body fat content in Asian populations. Proposed classification of weight by
BMI in adult Asians is underweight (<18.5 kg/m2), normal
(18.5-22.9 kg/m2), overweight (23.0-24.9 kg/m2) and obese
(⩾25 kg/m2).17

Statistical analysis
SPSS version 22 was used to perform statistical analysis of the
data. Descriptive analysis was performed for continuous variables and reported depending on the normality assumption of
the variables and assessed by independent t test or Wilcoxon
rank sum (Mann-Whitney test), respectively. Chi-square test
was used for categorical variables of independence if frequency
in each cell was ⩾ 5 and if frequency was found to be ⩽ 5 in any
cell, Fisher’s exact test was used. Kaplan-Meier survival curves
and log-rank tests and Cox proportional hazards regression
analysis were used to compare overall survival (death as endpoint). A second proportional hazard regression model adjusted
for the other covariates of the study were used to examine the
independent effect of treatment. Unadjusted and adjusted hazard ratio (HR) with their 95% CI was reported. A P value of
<.05 was considered as significant.

Results

We enrolled 386 participants diagnosed with OSCC in our
study. The study cohort comprised 296 males (76.7%) and 90
females (23.3%), with a mean age of 50.19 (SD ± 13.36). The
mean BMI of study participants was 24.4 (SD ± 5.25) and
42.7% of study population was found to be obese (⩾25 BMI).
Approximately 16.6% (64) participants had DM.
The mean BMI (25.7 ± 4.35) among DM patients was significantly higher compared with non-DM patients (24.17 ± 5.3)
(P value .01). Similarly, DM patients were older compared with
non-DM patients with a mean age of 59.70 ± 10.91 and
48 ± 12.97, respectively (P ⩽ .001). DM was found to be more
prevalent in obese patients and this claim was supported by the
calculation of 1.6% underweight patients that had DM whilst
56.3% obese patients had DM (P value .02) (Table 1).
Table 2 shows mean survival time of OSCC patients in
relation to demographic and clinicopathological characteristics. The mean overall survival time for the study population
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Table 1. Diabetes mellitus status in relation to demographic and clinicopathological characteristics among OSCC patients (n = 386).
Diabetes mellitus

P value

Yes

No

N

%

N

%

Male

48

75

248

77

Female

16

25

74

23

Gender
.727

Age (in years)
Mean (SD)
BMI (in kg/m2) Mean (SD)

59.7 (10.91)
25.71 (4.35)

48.30 (12.97)

⩽.001a

24.17 (5.389)

.01a

BMI (in kg/m2)
1

2

37

11

18.5-22.99 (normal weight)

16

25

105

33

23.0-24.99 (Overweight)

11

17

51

16

⩾25 (Obese)

36

56

129

40

<18.5 (underweight)

aTumour

.02a

size

Median (interquartile range)

2(2)

2(2)

.288

Tumour thickness
<5 mm

2

3

36

11

>5 mm

50

78

226

70

Unknown

12

19

60

18

No

34

53

159

49

Yes

27

42

139

43

3

5

24

7

Well differentiated

10

16

62

19

Moderately differentiated

47

73

206

64

Poorly differentiated

4

6

34

11

Unknown

3

5

20

6

.136

Lymph node involvement

Unknown

.69

Histological classification
.51

Follow up
Mean (SD)

19.45 (17.44)

19.027 (15.6)

.86

Overall survival
Alive

34

53

197

61

Expired

19

30

59

18

11

17

66

20

 LFUP

Abbreviations: BMI, body mass index; LFUP, lost to follow-up; OSCC, oral squamous cell carcinoma.
aMann-Whitney U test was used, significant at P value < .05.

.117
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Table 2. Mean survival time of OSCC patients compared with clinicopathological characteristics, BMI, and DM status.
Mean survival
(months)

Overall

P value

52.988

95% Confidence interval

Lower bound

Upper bound

47.751

58.225

50.468

62.281

31.479

42.866

20.802

39.000

Gender
Male

56.374

Female

37.172

.195

BMI
<18.5 (underweight)

29.901

.074

18.5-22.99 (normal weight)

57.988

48.726

67.250

23.0-24.99 (overweight)

40.845

33.597

48.092

⩾25(obese)

44.493

39.218

49.768

35.601

52.420

38.717

47.750

56.831

77.388

Tumour thickness
<5 mm

44.010

>5 mm

43.234

.796

Histological classification
.039*

Well differentiated

67.109

Moderately differentiated

41.679

37.276

46.082

Poorly differentiated

32.493

24.362

40.623

42.642

50.266

26.626

38.216

33.709

57.218

41.166

49.000

Lymph node involvement
No

46.454

Yes

32.421

⩽.001*

DM
Yes

45.464

No

45.083

.97

Abbreviations: BMI, body mass index; DM, diabetes mellitus; OSCC, oral squamous cell carcinoma.
*P value significant at < .05.

was 52 months. There was no significant difference in mean
survival times for OSCC patients having DM compared with
non-diabetic individuals. The mean overall survival time of
underweight patients was lower compared with those with
normal, overweight and obese individuals, but the difference
was not considered significant (P value = .074). Figure 1
shows the survival curves for patients based on diabetes status
and BMI.
The univariate analysis revealed that increasing age, larger
tumour size and lymph node involvement led to poor survival
(Table 3). Moreover, underweight individuals also had a significantly poorer survival (P value .019) compared with normal

weight individuals. Diabetes status was not a significant predictor of survival on univariate analysis.
To assess the independent effect of BMI on survival, multivariate analysis was performed which confirmed the univariate findings: underweight individuals had a higher risk of
death (P value .035), meaning that low BMI was an independent predictor for worse survival (Table 4). To study the interaction of BMI and DM, an interaction model was run (shown
in Table 4) with normal weight and non-diabetic individuals
serving as reference. However, the interaction of BMI and
DM was not statistically significant for survival. As observed
in the univariate analysis, older age, bigger tumour size and
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Figure 1. Kaplan-Meir overall survival curves of oral squamous cell carcinoma patients according to (left) body mass index categories (underweight,
normal weight, overweight and obese: P value = .74) and (right) diabetes mellitus status (Yes, No: P value = .97).
BMI indicates body mass index.

Table 3. Univariate analysis to assess the relationship of factors associated with survival of OSCC patients.
Variables

Reference value

Univariate unadjusted
HR

Gender

Male

1.36

Female (ref)

1

Age (in years)
BMI (in kg/m2)

1.01

Lymph node Involvement

Diabetes Mellitus

95.0% CI
Lower

Upper

0.84

2.19

.199

1.00

1.03

.046*

18.5-22.99 (normal weight) (ref)

1

<18.5 (underweight)

2.478

1.159

5.298

.019*

23.0-24.99 (overweight)

1.350

0.655

2.784

.416

⩾25 (obese)

1.347

0.754

2.407

.315

1.24

1.10

1.39

<.001*

Tumour size (mm)
Tumour classification

P value

Well differentiated

1

.055

Moderately differentiated

2.69

1.226

5.903

Poorly differentiated

3.75

1.394

10.119

No (ref)

1

Yes

2.909

1.826

4.637

<.001*

Unknown

0.282

0.039

2.074

.214

Yes

1.54

0.918

2.58

.102

No

1

Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazard ratio; OSCC, oral squamous cell carcinoma.
*P value significant at < .05.
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Table 4. Multivariate analysis to assess the relationship of factors associated with survival of OSCC patients.
Variables

Adjusted hazard ratio

95% CI

P value

Diabetes
No (ref)

1

Yes

1.216

0.677

2.185

.512

BMI
18.5-22.99 (normal weight) (ref)

1

<18.5 (underweight

2.523

1.066

5.969

.035*

23.0-24.99 (overweight)

1.400

0.642

3.052

.397

⩾25 (obese)

1.566

0.843

2.910

.156

Tumour size (mm)

1.185

1.038

1.352

.012*

Lymph node involvement
No (ref)

1

Yes

3.079

1.862

5.094

<.001*

Unknown

0.473

0.064

3.522

.465

Age (in years)

1.026

1.008

1.045

.006*

.421

Multivariate analysis with interaction
Diabetes × BMI
   Non-diabetic and normal weight (ref)

1

   Diabetic and normal weight

0.583

0.157

2.171

271.271

14.654

5021.797

   Diabetic and overweight

0.829

0.181

3.801

.809

   Diabetic and obese

2.045

0.873

4.793

.100

   Non-diabetic and underweight

1.869

0.753

4.636

.177

   Non-diabetic and overweight

1.379

0.578

3.292

.469

   Non-diabetic and obese

1.170

0.575

2.380

.664

   Diabetic and underweight

.10

Abbreviations: BMI, body mass index; CI, confidence interval; OSCC, oral squamous cell carcinoma.
*P value significant at <.05 by cox regression analysis.

lymph node involvement were all significant predictors for
worse survival on the multivariate as well.

Discussion

The present study investigated the role of obesity and DM as
possible prognostic indicators for overall survival in a cohort of
386 OSCC patients. The mean BMI was significantly higher in
the diabetic versus non-diabetic group (P value .01), and the diabetic group was also significantly older than non-diabetic individuals (P value ⩽ .001). A significant interaction between
underweight BMI and survival was recognized (P value .035) on
multivariate analysis as an independent predictor for survival.
The frequency of obesity among OSCC patients was about
42.7%, while 16 % of patients were overweight. Mean overall

survival time for the study population was 52 months. The
findings of this study substantiate the data of another study
conducted on head and neck squamous cell carcinoma
(HNSCC) which suggested that being overweight or obese
was an independent prognostic factor for improved survival.18
The possible explanation for this lies in the fact that obese
people have unusually replenished energy stores which exhibit
a protective effect. Therefore, in this study the energy stores
among obese patients might have protected them from wastage of energy and inflammation. This provides reinforcement
of the previous research confirming the action of adipose tissue as a buffer, in addition to providing an evolutionary survival advantage.19 In the authors’ experience, it has been
observed that adjuvant therapy in the form of radiation and

Adnan et al
chemotherapy is difficult to endure and has several detrimental health effects, which are often well-tolerated in patients of
normal or above-normal BMI. Moreover, most patients present with advanced disease, and this further complicates their
treatment and survival. Previously published work by the same
authors on thyroid cancer also unveiled the majority of patients
to be obese and female.20 This tentatively suggests a trend of
obesity among various cancer patients in Pakistan and further
larger studies encompassing other cancer types might be able
to highlight causative factors.
Although in this cohort, diabetes was not a significant predictor for survival, however, other studies have suggested a significant impact of DM on the overall survival of OSCC
patients.14 The majority of our study participants were male
and previous studies suggest that men are more likely to sustain
better metabolic control, directing to less levels of insulin and
causing lesser oxidative damage to DNA, which might be a
possible explanation for these results.15
The frequency of DM in our OSCC patient cohort was
about 16.6%. A study conducted in Hungary, known for a high
incidence of type 2 diabetes and oral cancer, showed 25.9%
prevalence of DM amongst oral cancer cases, highlighting a
steady increase in the incidence of type 2 diabetes among oral
cancer patients in the last 14 years.21 In addition, our study
results illustrated that about 83.4% OSCC patients were nondiabetic but no significant association of DM with OSCC was
detected. A large pooled analysis of 12 case-control studies
includes Asian, Hispanic, non-Hispanic White, and black
races from 12 countries indicated a weak association between
diabetes and Head and Neck cancer (HNC).22 In our study
the frequency of diabetes was lower among OSCC patients
and the possible explanation of this is that it was a hospitalbased study and in such studies prevalence cannot be determined. Therefore, to depict prevalence community-based
studies are more appropriate. Furthermore, with limited access
to healthcare facilities the possibility of unscreened cases of
diabetes amongst the less privileged population must also be
considered.
Moreover, our study results indicated that the mean overall
survival time was equivalent in both males and females, which
is in line with previous studies suggesting no significant difference in overall survival based on gender.23
The study results also revealed that increasing age escalated
the risk of death among oral cancer patients. These findings are
consistent with reports from the previous literature; however,
there is insufficient information regarding correlation of age
and survival among oral cancer patients.24
In the present cohort, longer survival was observed amongst
patients with uninvolved lymph nodes compared with those
with involved lymph nodes, which is a well-established predictor for survival. Similarly, consistent with other reports,25,26 our
results suggested a high mean survival time in patients with
well differentiated tumours which gradually decreased from

7

moderate to poorly differentiated tumour patients with worse
survival (P value .039).
Diabetes can have a negative impact on oral health.27,28 A
WHO factsheet has predicted that by 2030, DM will be the
seventh leading cause of death in the world, and approximately
80% of these deaths are projected to occur in low-to-middle
income countries.29 There is a dearth of information from
Pakistan regarding the association of BMI and DM, and their
prognostic role in OSCC. The findings of this study cannot be
generalized on the overall population as it was a hospital-based
study and there is an indisputable need for community-based
studies for in-depth evaluation. But we can generalize our
results to patients presenting to other tertiary care hospitals of
Pakistan. Since these patients all underwent surgical resection,
many of them later underwent radio- or chemotherapy as well.
However, a large portion of these patients opted for public hospitals for these services due to economic reasons. Hence, due to
missing information correlations between different adjuvant
treatments could not be incorporated. Larger, multicentre prospective cohort analysis are warranted to fully elucidate the role
of DM and BMI as prognostic factors for OSCC.

Conclusions

It is suggested that BMI may serve as an independent predictor
of survival in OSCC patients, as underweight patients were
seen to be at a higher risk of adverse outcome compared with
normal weight individuals. In this cohort, diabetes status did
not influence the survival of OSCC patients. Awareness campaigns and counselling of patients may be implemented so that
the general population is made aware of the possible risks associated with obesity and a culture of regular exercise and healthy
lifestyle may be promoted to maintain a healthy bodyweight.
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